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Abstract
Background: Adiponectin greatly stimulated the expression of matrix metalloproteinases (MMPs) in fibroblast-like
synoviocytes (FLSs) as did IL-1b. We wondered whether taurine chloramine (TauCl) inhibits the production of MMPs
stimulated by adiponectin in the same pattern as by IL-1b stimulation in vitro
Methods: Synovial cells from rheumatoid arthritis (RA) patients were treated with adiponectin or interleukin (IL)-1b
for 24 hr in the presence or absence of TauCl. The culture supernatant was collected and the levels of MMPs were
measured by enzyme-linked immunosorbent assay (ELISA). The IB signaling pathways stimulated by adiponectin
were studied and the levels of NF-B in the nuclei of the cells were analyzed by ELISA.
Results: TauCl (600 µM) inhibited MMP-13, but not MMP-1, expression in IL-1b-stimulated RA FLSs. However, TauCl
at the same concentration significantly inhibited the production of both adiponectin-stimulated MMP-1 and MMP-
13 expression. TauCl inhibited the degradation of IB-a stimulated by adiponectin, but not by IL-1b. Similarly, the
level of NF-B in the nucleus was increased by adiponectin stimulation and was inhibited by 600 µM TauCl.
However, the levels of NF-B increased by IL-1b stimulation were not inhibited by 600 µM TauCl.
Conclusions: TauCl more effectively inhibited MMPs expression induced by adiponectin than that by IL-1b in RA
FLS, suggesting that TauCl plays an important role in down-regulating the expression of MMPs in arthritic joints.
Background
One of the characteristics of rheumatoid arthritis (RA) is
the infiltration of inflammatory immune cell types into
the synovial fluid of the joints. Proliferative fibroblast-
like synoviocytes (FLS) play crucial roles in the propaga-
tion of inflammation because they produce many media-
tors of inflammation [1]. Immune cells recruited into
joint cavities by FLS also contribute to the progressive
destruction of the cartilage in distal joints [2]. Among
the detrimental immune cells present in RA joints, neu-
trophils have been a primary focus of research in RA
due to their number and function [3-5]. Polymorpho-
nuclear neutrophils (PMNs) are usually thought of as
the leukocyte population involved in the acute inflam-
matory response, acting as a first line of defense against
invading microorganisms [6]. As such, neutrophils are
crucial for pathogenesis defense as part of the innate
immunity. However, neutrophils can themselves produce
an array of inflammatory mediators, including cytokines,
chemokines, and complement [7]. In addition, they
release granule-packaged proteases such as matrix
metalloproteinases (MMPs) and reactive oxygen inter-
mediates such as nitric oxide (NO) and hypochlorous
acid (HOCl) for intracellular digestion during phagoc-
ytosis [8,9]. Thus, neutrophils seem to play an important
role in the pathogenesis of RA [5].
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peroxidase-H2O2-Cl system in the phagocytotic process
of neutrophils, reacts with amino acids, carbohydrates,
nucleic acids and lipids and thus contributes to the
mutagenic and cytotoxic effects of phagocytes on micro-
bial pathogens [10]. After clearance of pathogens, the
accumulated HOCl should be removed because a high
concentration of HOCl can affect the host tissue. Thus,
activated neutrophils have developed homeostatic
mechanisms for neutralizing the cytotoxic HOCl by pro-
ducing high levels of taurine, which is one of the most
abundant free intracellular amino acids in mammalian
tissue and blood cells. Taurine reacts with HOCl to
form taurine chloramine (TauCl) by acting as a scaven-
ger of HOCl [11]. Most notably, TauCl has been shown
to play a major role in down-regulating the expression
of inflammatory mediators such as chemokines, cyto-
kines, cyclooxygenase-2 (COX-2), and inducible nitric
oxide synthase (iNOS) in different cell types [12-15].
TauCl also differentially inhibits the expression of
MMP-1 and MMP-13, which play dominant roles in RA
and osteoarthritis (OA), in IL-1b-stimulated fibroblast-
like synoviocytes (FLS) [16].
Adipose tissue, once viewed as simply a storage and
release depot for lipids, is now considered an endocrine
tissue [17,18] that secretes various substances (adipo-
kines) including tumor necrosis factor-a (TNF-a), inter-
leukin-6 (IL-6), leptin, adiponectin, resistin, visfatin,
omenetin, and others [19,20]. Recent findings suggest
that adiponectin may be involved in the pathogenesis of
rheumatoid arthritis (RA). However, the role of adipo-
nectin in the pathogenesis of RA is still controversial
because of conflicting reports about its function.
Recently we found that adiponectin may contribute to
synovitis and joint destruction in patients with RA by
stimulating VEGF, MMP-1, and MMP-13 expression
more than proinflammatory mediators in fibroblast-like
synoviocytes [21]. However, it remains to be determined
whether adiponectin or IL-1b contributes more to the
increased expression of these MMPs in arthritic joints
and it also should be determined whether TauCl inhibits
the production of MMPs stimulated by adiponectin and
those stimulated by IL-1b in vitro.I nt h i ss t u d y ,w e
investigated the specific inhibitory effect of TauCl by
showing that TauCl differentially inhibits MMPs expres-
sion in IL-1b- or adiponectin-stimulated FLSs.
Methods
Primary fibroblast-like synoviocytes (FLS) culture
After obtaining informed consent, synovial tissues were
collected from RA patients who met the 1987 American
College of Rheumatology criteria for the diagnosis of RA
and who were undergoing therapeutic joint surgery. FLS
were isolated as described previously [16]: tissues were
digested with gentle shaking in 20 ml of RPMI 1640
(Gibco-BRL, Grand Island, NY, USA) containing 1 mg/
ml collagenase (Gibco-BRL) at 37°C for 90 min, filtered
through a 70-μm cell strainer, and cultured in 75-cm
2
culture flasks with Dulbecco’s Modified Essential Med-
ium (DMEM; Gibco-BRL) supplemented with 20% (v/v)
fetal bovine serum (FBS; Gibco-BRL) and 1× antibiotic-
antimycotic (Gibco-BRL). After the cells had grown to
confluence, they were detached with 0.25% trypsin
(Gibco-BRL) and split at a 1:4 ratio. FLS were used at
passages 3-6 for all experiments. Visual examination of
cell morphology under light microscopy and FACS ana-
lysis of cells stained with anti-CD11b antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) confirmed
that FLS accounted for more than 95% of the cells.
Preparation of TauCl
TauCl was synthesized by mixing equimolar amounts of
NaOCl (Aldrich Chemical, Milwaukee, MI, USA) and
taurine (Sigma, St. Louis, MO, USA). TauCl formation
was verified by ultraviolet (UV) absorption (200–400
nM) [22]. Endotoxin-free or low-endotoxin grade water
and buffers were used. Stock solutions of TauCl were
kept at 4°C and used within 3 days.
Enzyme-linked immunosorbent assay (ELISA)
The levels of MMP-1 and MMP-13 secreted in the cul-
ture media by IL-1b-stimulated FLS (2.5 × 10
5 cells/60-
mm dish/2-ml serum-free media) in the presence or
absence of TauCl were measured by enzyme-linked
immunosorbent assay (ELISA; R&D Systems, Inc., Min-
neapolis, MN, USA). For the measurement of transcrip-
tion factors, NF-B and AP-1, in the nucleus, FLSs were
seeded (5 × 10
6 cells) into 100-mm dishes and grown to
80% confluence. The cells were serum-starved overnight
and stimulated by adiponectin (10 µg/ml) or IL-1b
(10 ng/ml) for 120 min and 90 min, respectively, in the
presence or absence of TauCl (600 µM). The cells were
then washed twice in PBS and treated with lysis buffer;
the transcription factors were extracted from the
nucleus according to the manufacturer’sp r o t o c o l
(Active Motif, Seoul, Korea).
Semi-quantitative RT-PCR
After the culture supernatants were harvested, the cells
were used for semi-quantitative RT-PCR. TRIzol®
reagent (Invitrogen) was used to extract total RNA from
the cells. Complementary DNA was synthesized from
1 μg of total RNA in 20 μl of reverse transcription reac-
tion mixture containing 5 mM MgCl2, 1× RT buffer,
1m Md N T P ,1U / µ lo fR N a s ei n h i b i t o r ,0 . 2 5U / μlo f
AMV reverse transcriptase, and 2.5 μMr a n d o m9 - m e r s .
For semi-quantitative PCR, aliquots of cDNA were
amplified with the primers in a 25-μlP C Rm i x t u r e
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Taq
TM HS, and 0.2 μM of specific upstream primers,
according to the manufacturer’s protocol (TaKaRa Bio,
Kyoto, Japan). The PCR conditions for the MMPs were
as follows: 30–33 cycles of 95° C for 45 sec, 55–60° C
for 45 sec, and 72° C for 45 sec. PCR products were
subjected to electrophoresis in 1.5% agarose gels con-
taining ethidium bromide, and the bands were visualized
under UV light. The primers were synthesized by Bio-
neer Co. Ltd. (Seoul, Republic of Korea); their sequences
are listed in Table 1.
Western blot analysis
FLS cultured (5 × 10
5 cells) in 60-mm dishes were
serum-starved overnight and stimulated by IL-1b (10
ng/ml) or adiponectin (10 µg/ml) for 30 min or 60 min,
respectively, in the presence or absence of TauCl. The
cells were subsequently washed twice in PBS and treated
with 50 μlo fl y s i sb u f f e r[ 2 0m MT r i s –Cl (pH 8.0), 150
mM NaCl, 1 mM EDTA, 1% Triton X-100, 20 µg/ml
chymostatin, 2 mM phenylmethylsufonyl fluoride
(PMSF), 10 µM leupeptin, and 1 mM 4-(2-aminoethyl)
benzenesulfonyl fluoride (AEBSF)]. Cells were scraped
using a rubber policeman prior to the addition of
another 50 μl of lysis buffer. The cells were transferred
to a microcentrifuge tube, incubated on ice for 30 min
with occasional agitation every 5 min, and centrifuged
for 15 min at 12,000 rpm (16,090 × g), and the superna-
t a n tw a st h e na n a l y z e df o rp r o t e i nc o n c e n t r a t i o nu s i n g
the Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA,
USA). Thirty µg of cytoplasmic protein extract were
then boiled in 5× Laemmli sample buffer for 5 minutes.
The samples were separated by 12% SDS-PAGE and
transferred to Hybond-ECL membranes (Amersham,
Arlington Heights, IL, USA). The membranes were
blocked with 6% nonfat milk dissolved in TBST buffer
[10 mM Tris–Cl (pH 8.0), 150 mM NaCl, 0.05% Tween
20]. The blots were probed with rabbit polyclonal anti-
bodies against IBa and b-actin (Cell Signaling Tech-
nology, Beverly, MA, USA) diluted 1:1000 in TBS for 2
h and then incubated with 1:1000 dilution of horserad-
ish peroxidase-conjugated goat anti-rabbit IgG second-
ary antibody. The blots were developed using the ECL
method (Amersham). For re-probing, the blots were
incubated in stripping buffer [100 mM 2-mercaptoetha-
nol, 2% SDS, 62.5 mM Tris–HCl (pH 6.7)] at 50° C for
30 min with occasional agitation.
Statistical analysis
All experiments were repeated three times, and the
results are expressed as the mean ± standard deviation.
Statistical evaluation was performed by the Mann-Whit-
ney test. Differences were considered statistically signifi-
cant at P<0.05.
Results
Differential inhibition of the production of pro-MMP1-
and pro-MMP-13 by taurine chloramine in adiponectin- or
IL-1b-stimulated FLSs
To investigate whether TauCl inhibits the production of
MMPs stimulated by adiponectin in the same pattern as
it inhibits that by IL-1b in vitro, fibroblast-like synovio-
cytes (FLSs) were cultured and stimulated with adipo-
nectin (10 µg/ml) or IL-1b (10 ng/ml) in the presence
or absence of 600 µM TauCl (Fig. 1A). Adiponectin and
IL-1b significantly stimulated the expression of pro-
MMP-1 and pro-MMP-13 in FLSs. Similarly, the mRNA
level of pro-MMPs was also significantly increased in
the FLSs. TauCl (600 µM) could not inhibit the IL-1b-
induced increase in pro-MMP-1; however, it signifi-
cantly inhibited the level of pro-MMP-13 by about 3-
fold, even at 400 µM. At 600 µM, TauCl also inhibited
the level of pro-MMP-13 by about 10-fold in IL-1b-sti-
mulated FLSs as shown previously [16]. In contrast,
TauCl at 400 µM significantly inhibited the level of pro-
MMP-1 in adiponectin-stimulated FLSs and further
inhibited the expression of pro-MMP-1 by about 2-fold
at 600 µM. In addition, even 400 µM TauCl greatly
inhibited the expression of pro-MMP-13 to the basal
expression level of non-stimulated FLSs. Similarly, the
mRNA level of pro-MMPs was inhibited by TauCl as
shown in Fig. 1B.
Effect of taurine chloramine on the degradation of IB-a
by adiponectin or IL-1b stimulation
To explain the differential effect of TauCl on the pro-
duction of pro-MMPs in FLSs, the signaling pathway
was investigated in adiponectin-stimulated FLSs. First,
the signaling pathway was investigated in a time course
and compared with that of IL-1b (Fig. 2). Adiponectin
seems to activate the IB kinase signaling pathway, but
it did not affect the mitogen-activated protein kinase
(MAPK) (Fig. 2A). The degradation of IB-a was the
highest at 60 min of adiponectin stimulation. The time
course change of IB-a degradation during adiponectin
stimulation was different from that of IL-1b as reported
previously elsewhere [16]. More importantly, the IB-a
Table 1 Sequences of PCR primers used in this study
Primer name Primer sequence Product size
MMP-1 sense 5′-CCT AGC TAC ACC TTC AGT GG-3′
MMP-1 antisense 5′-GCC CAG TAC TTA TTC CCT TT-3′ 338 bp
MMP-13 sense 5′-TTG AGG ATA CAG GCA AGA CT-3′
MMP-13
antisense
5′-TGG AAG TAT TAC CCC AAA TG-3′ 311 bp
b-actin sense 5′-TCA TGA GGT AGT CAG TCA GG-3′
b-actin antisense 5′-CTT CTA CAA TGA GCT GCG TG-3′ 305 bp
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Page 3 of 7Figure 1 Effect of taurine chloramine on the expression of MMPs in adiponectin- or IL-b-stimulated FLSs. The expressions of the
collagenases (MMP-1 and MMP-13) were determined by ELISA [A], and semi-quantitative RNA analysis [B]. Synovial cells (2.5 × 10
5 cells/60-mm
dish/2-ml serum-free media) were treated with taurine chloramine (TauCl) for 30 min prior to 24 h of adiponectin (10 µg/ml) or IL-1b (10 ng/ml)
stimulation for analysis of MMP proteins by ELISA. Supernatants were collected for ELISA and the cells were used for RNA extraction for semi-
quantitative RT-PCR. Experiments were performed in quadruplicate with cells from patients. The experiments were repeated with FLSs from three
patients. The data shown are representative of 3 independent experiments, and similar results were obtained from all 3. Values are expressed as
mean ± S.E.M. *P<0.05, **P<0.01, and *** P<0.001 versus non-treated group.
Figure 2 Effect of taurine chloramine on the signaling pathways stimulated by adiponectin. (A) Synovial cells (5 × 10
5 cells/60-mm dish/
2-ml serum-free media) were treated with adiponectin (10 µg/ml). Time courses of the signaling pathways activated during adiponectin
stimulation. (B) Synovial cells (5 × 10
5 cells/60-mm dish/2-ml serum-free media) were treated with TauCl 30 min prior to 30- or 45-min
adiponectin (10 µg/ml) or IL-1b (10 ng/ml) stimulation, respectively. TauCl (600 µM) significantly inhibited the IB-NF-B signaling pathway by
inhibiting the degradation of IB-a induced by adiponectin, but not that by IL-1b. The data shown are representative of 3 independent
experiments, and similar results were obtained from all 3.
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ited by 600 µM TauCl. However, the degradation of
IB-a stimulated by IL-1b was not affected by 600 µM
TauCl.
Effects of taurine chloramine on NF-B migration into the
nucleus by adiponectin or IL-1b stimulation
To assess whether the inhibition of IB signaling path-
ways by TauCl also inhibits the migration of NF-B into
the nucleus, the levels of the transcription factors NF-
B were measured in adiponectin- or IL-1b-stimulated
FLSs in the presence or absence of TauCl. As shown in
Fig. 3, the level of NF-B was increased in the nuclei of
adiponectin- or IL-1b-stimulated FLSs. At 600 µM,
TauCl significantly inhibited the migration of NF-B
into the nuclei of adiponectin-stimulated FLSs. How-
ever, it slightly inhibited the migration of NF-Bi n t o
the nuclei of IL-1b-stimulated FLSs with no statistical
significance, even though it did not inhibit the degrada-
tion of IB-a. All of these results suggest that TauCl
plays a more important role in down-regulating the
expression of MMPs in arthritic joints than expected.
Discussion
MMPs, which are primarily produced in fibroblast-like
synoviocytes (FLS) in RA, are proteases that participate
in irreparable proteolytic degradation and the remodel-
ing of the extracellular matrix. According to their sub-
strate specificities, primary structures, and cellular
localizations, MMPs can be classified into five main
groups: collagenases (MMP-1, MMP-8, MMP-13), gela-
tinases (MMP-2, MMP-9), stromelysins (MMP-3, MMP-
10), matrilysins (MMP-7, MMP-26), and membrane-
bound MT-MMPs (MMP-14, MMP-15, MMP-16,
MMP-17, MMP-24, MMP-25) [23]. In particular, the
MMP-1 and MMP-13 collagenases play dominant roles
in RA and osteoarthritis. The collagenases have the
unique ability to cleave the triple helix of collagen,
thereby allowing the chains to unwind; the chains then
become susceptible to further degradation by other
MMPs such as gelatinase (MMP-2 and MMP-9). Thus,
the collagenases can be regarded as rate-limiting compo-
nents of the collagen degradation process [24,25]. In
addition, MMP-13 is a potent protease that is capable of
degrading a wide range of collagenous and noncollagen-
ous extracellular matrix macromolecules [26,27]. MMP-
13 is remarkably active against collagen type II, the pre-
dominant collagen in cartilage [28]. Thus, it is necessary
to understand the factors to control the expression of
these collagenases in arthritic joints.
It has not yet been determined whether adiponectin or
IL-1b contributes more to the increased expression of
these MMPs in arthritic joints, but the high concentra-
tion of adiponectin in joint fluids of patients with arthri-
tis seems to contribute significantly to the joint
degradation. In this study, TauCl showed a greater inhi-
bitory effect on the expression of MMP-1 and MMP-13
induced by adiponectin than by IL-1b. Thus, TauCl may
Figure 3 Effects of taurine chloramine on transnuclear migration of NF-B. FLSs were seeded (5 × 10
6 cells) into 100-mm dishes and
grown to 80% confluence. The cells were serum-starved overnight and stimulated by adiponectin (10 µg/ml) or IL-1b (10 ng/ml) for 120 min
and 90 min, respectively, in the presence or absence of TauCl (600 µM). The nuclear levels of NF-B were measured by ELISA detection of p65 in
nuclear extracts. TauCl differentially inhibited the level of NF-B in the nuclei of adiponectin- or IL-1b-stimulated RA FLSs. Values are expressed ±
S.E.M. *p<0.05 versus adiponectin- or IL-1b-treated group in the presence of TauCl. ns, not significant.
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joints, considering that the physiological concentration
of adiponectin is high in arthritic joints. The inhibition
of MMP-13 expression with lower concentrations of
TauCl would also be a potentially effective strategy for
controlling the destruction of joint cartilage in RA and
OA. In addition, TauCl may be produced as a part of
the homeostatic response to infection and inflammation,
thus playing a critical role in limiting the duration and
intensity of immune inflammation [15]. In support of
this hypothesis, synovial fluid neutrophils of RA patients
showed impaired generation of TauCl [29]; thus, the
involvement of TauCl in the pathogenesis of arthritis
should be studied further.
To elucidate the molecular mechanisms by which
TauCl more effectively inhibits adiponectin-induced
MMPs expression than that induced by IL-1b, the levels
of MAPK phosphorylation and IB degradation in adi-
ponectin-stimulated FLSs were compared with those of
IL-1b. Adiponectin did not stimulate the phosphoryla-
tion of ERK1/2, p38, or JNK in the MAP kinase signal-
ing pathways, but rather stimulated the signaling
pathways of IBk i n a s et h r o u g hI B-a degradation. In
contrast, IL-1b stimulated both pathways as reported
previously [16]. At 600 µM, TauCl did not significantly
inhibit IB degradation stimulated by IL-1b,b u tg r e a t l y
inhibited the degradation stimulated by adiponectin.
Meanwhile, we previously reported that partial inhibi-
tion of IB-a degradation was seen with 600 µM TauCl,
as evidenced by NF-B immunostaining in both the
cytoplasm and the nucleus, and IB-a degradation was
completely inhibited by 800 µM TauCl, thereby prevent-
ing the migration of NF-B into the nucleus [16]. In
this study, however, the inhibition of adiponectin-
mediated IB-a degradation by TauCl did not signifi-
cantly inhibit the migration of NF-B into nucleus. In
addition, at 600 µM, TauCl did not show an inhibitory
effect on IB-a d e g r a d a t i o ni nI L - 1 b stimulation based
on Western blot analysis, but the IL-1b-induced migra-
tion of NF-B into nucleus was partially inhibited. This
may indicate that TauCl partially inhibits the activation
of NF-Bi nI L - 1 b stimulation through unknown
mechanisms. In other words, signaling pathways other
than the IBk i n a s ep a t h w a ym a yb ea f f e c t e db ya d i p o -
nectin or IL-1b and be involved in the stimulation of
MMP-1 and MMP-13 through other transcription fac-
tors in addition to NF-B. For example, protein kinase
C (PKC) delta is known to play a key role in the stimu-
lation of MMP-13 via cross-talk with MAP kinases in
basic fibroblast growth factor (bFGF)-stimulated human
adult articular chondrocytes [30]. The differential effects
of TauCl on the expression of MMPs induced by adipo-
nectin or IL-1b may also be related to other transcrip-
tion factors that are differentially activated by
adiponectin versus IL-1b. Many transcriptional binding
sites, such as AP-1, Ets/polyomavirus enhancer 3 (OS-2)
and Runx2 sites, have been identified in the human
MMP-13 proximal promoter [31-33]. An AG-rich ele-
ment (AGRE) regulatory site was recently found in the
human MMP-13 proximal promoter [34]. These or
other transcription factors may therefore differentially
contribute to the increased expression of MMPs in adi-
ponectin- or IL-1b-stimulated FLS. TauCl may differen-
tially inhibit the activation of these transcription factors
by adiponectin or IL-1b.
T a u C li sl e s st o x i ct h a ni t sp r e c u r s o rH O C l / O C l
-,b u t
cytotoxic effects of TauCl at high concentrations have
been reported. Its toxicity seems to differ between cell
types [35]. Kontny et al. reported that TauCl caused
progressive necrosis of RA FLS at ≥500 µM [36]. How-
ever, in our previous report, TauCl toxicity seemed to
vary according to the individual RA patient [16]. In
addition, different cell passages may contribute to the
variance in sensitivity to TauCl, since RA FLS show dif-
ferent characteristics according to passage [37,38]. Thus,
the differential inhibitory effect of TauCl may indirectly
indicate that TauCl inhibits a specific reaction in adipo-
nectin- or IL-1b-stimulated FLSs rather than a cytotoxic
or nonspecific reaction.
Conclusions
TauCl more effectively inhibited MMPs expression
induced by adiponectin than that by IL-1b in RA FLS,
suggesting that TauCl plays an important role in down-
regulating the expression of MMPs in arthritic joints.
Furthermore, its mode of action is based on a specific
reaction, rather than a cytotoxic or nonspecific reaction.
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